Ubs Asset Management Americas Inc Rocket Pharmaceuticals, Inc. Transaction History
Ubs Asset Management Americas Inc
- $379 Billion
- Q1 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 184,692 shares of RCKT stock, worth $463,576. This represents 0.0% of its overall portfolio holdings.
Number of Shares
184,692
Previous 139,572
32.33%
Holding current value
$463,576
Previous $1.75 Million
29.82%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding RCKT
# of Institutions
258Shares Held
108MCall Options Held
555KPut Options Held
177K-
Rtw Investments, LP New York, NY17.7MShares$44.4 Million1.93% of portfolio
-
Wellington Management Group LLP Boston, MA12.6MShares$31.7 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.62MShares$16.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$15.5 Million0.0% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx5.2MShares$13.1 Million0.68% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $190M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...